Luye Life Sciences

Luye Life Sciences Group is a leading international life sciences enterprise that operates across three main business segments: Luye Pharma, Luye Medical, and Luye Investment. The group's pharmaceutical division, Luye Pharma, is a publicly traded company specializing in the development and commercialization of innovative therapies for central nervous system disorders, oncology, cardiovascular diseases, and metabolism. Luye is globally recognized for its advanced drug delivery platforms, particularly in the fields of long-acting microspheres, liposomes, and transdermal patches. Its healthcare services arm, Luye Medical, manages an extensive network of hospitals and specialized clinics across several countries, including Australia and China. With a strong R&D presence in China, the U.S., and Europe, the company aims to provide high-quality medical solutions to patients worldwide.